Effect of simvastatin on nuclear factor-κB synthesis in patients with variant angina stimulated by C reactive protein

ZHU Cheng-gang,LI Jian-jun,LIU Jun,GUO Yuan-lin,WU Na-qiong,LI Xiao-lin,TANG Yi-da,JIANG Li-xin

DOI: https://doi.org/10.3969/j.issn.1002-266X.2012.24.003

2012-01-01

Abstract:Objective To investigate whether nuclear factor-κB(NF-κB) might be involved in the pathogenesis of variant angina(VA) and the effect of simvastatin on C-reactive protein(CRP)-dependent inflammatory activation in monocytes of patients with VA.Methods Monocytes of patients with VA(VA,n=6) and normal controls(controls,n=6) were cultured and stimulated with 20 mg/L of CRP for 24 hours.Also 10 μmol/L of simvastatin was pre-incubated for 2 hours with monocytes in the presence of CRP.The levels of NF-κB were evaluated by enzyme-linked immunosorbent assay(ELISA).Results The levels of NF-κB in baseline status were similar in patients with VA and normal controls.The levels of NF-κB induced by CRP were significantly elevated both in VA and normal controls compared with their baseline status(P<0.01).Patients with VA were detected to have significantly higher NF-κB levels induced by CRP in comparison with normal controls(P<0.01).Simvastatin significantly inhibited the production of NF-κB in monocytes stimulated by CRP both in VA and in normal controls(P<0.01).Conclusions CRP could induce more NF-κB release in human monocytes of patients with VA than normal controls,suggesting that an enhanced inflammatory response to CRP may be involved in the pathogenesis of VA.Simvastatin could inhibit this response which could provide an insight into the machnisms of anti-inflammation in statins.